Published

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Scientific reports
Date: 2024-02-05
Source: PubMed
DOI: 10.1038/s41598-024-53188-9
PubMed: 38316896

Authors

Breeksema JJ Niemeijer A Krediet E Karsten T Kamphuis J Vermetten E van den Brink W Schoevers R

Watch author

Derived topics and classifications

psilocybin Depression Aging Clinical Trial Treatment-Resistant Depression Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01 Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26 Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.2024-02-05

Related papers

Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29